A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project

Palliative Medicine

Volumn 26, Issue 4, 2012, Pages 294-304

  Ries, Anke ^a   Trottenberg, Peter ^b   Elsner, Frank ^a   Stiel, Stephanie ^c   Haugen, Dagny ^d,e   Kaasa, Stein ^d,f   Radbruch, Lukas ^g  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF AACHEN MEDICAL CENTER   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

Cancer cachexia; eicosapentaenoic acids; fish oil; guidelines; omega 3 fatty acids; systematic review

Indexed keywords

ALBUMIN; FISH OIL; GLUTAMINE; ICOSAPENTAENOIC ACID; MEGESTROL ACETATE; OMEGA 3 FATTY ACID; PREALBUMIN; TRANSFERRIN;

ABDOMINAL DISCOMFORT; ADVANCED CANCER; CACHEXIA; CANCER SURVIVAL; CAPSULE ENDOSCOPE; CENTRAL NERVOUS SYSTEM DISEASE; DIARRHEA; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FLATULENCE; HUMAN; INCIDENCE; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; STEATORRHEA; SUPPLEMENTATION; SYSTEMATIC REVIEW; TASTE AVERSION; TREATMENT DURATION; WEIGHT REDUCTION;

CACHEXIA; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 84861813698     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216311418709     Document Type: Review

References (46)

1. Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, et al. Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol. 2008 ; 26: 3867-3873
2. Fearon KSF, Anker SD, Bosaeus I, Bruera E, Fainsinger R, Jatoi A, et al. Definition and classification of cancer cachexia: an international consensus framework. Lancet Oncol. 2011 ; 12: 489-495
3. Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT, et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005 ; 5: 25
4. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, Garcia-Peris P, Garcia-de-Lorenzo A, Zarazaga A, et al. N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007 ; 97: 823-831 (Pubitemid 46554396)
5. Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004 ; 90: 996-1002 (Pubitemid 38495818)
6. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999 ; 129: 1120-1125 (Pubitemid 29250159)
7. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer. 1999 ; 81: 80-86 (Pubitemid 29415495)
8. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond). 2000 ; 98: 389-399 (Pubitemid 30197852)
9. Barber MD, Fearon KC. Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids. 2001 ; 36: 347-351 (Pubitemid 32433867)
10. Barber MD, Fearon KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2001 ; 40: 118-124 (Pubitemid 34274917)
11. Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003 ; 21: 129-134
12. Burns CP, Halabi S, Clamon GH, Hars V, Wagner BA, Hohl RJ, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999 ; 5: 3942-3947 (Pubitemid 30013768)
13. Burns CP, Halabi S, Clamon G, Kaplan E, Hohl RJ, Atkins JN, et al. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer. 2004 ; 101: 370-378 (Pubitemid 38890842)
14. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003 ; 52: 1479-1486 (Pubitemid 37176729)
15. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998 ; 82: 395-402 (Pubitemid 28060258)
16. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 ; 22: 2469-2476 (Pubitemid 41115406)
17. Kenler AS, Swails WS, Driscoll DF, DeMichele SJ, Daley B, Babineau TJ, et al. Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg. 1996 ; 223: 316-333 (Pubitemid 26086724)
18. Swails WS, Kenler AS, Driscoll DF, DeMichele SJ, Babineau TJ, Utsunamiya T, et al. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. J Parenter Enteral Nutr. 1997 ; 21: 266-274 (Pubitemid 27408644)
19. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996 ; 12: S27 - S30
20. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000 ; 36: 177-184 (Pubitemid 30437038)
21. Zuijdgeest-Van Leeuwen SD, Dagnelie PC, Wattimena JL, Van den Berg JW, Van der Gaast A, Swart GR, et al. Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation. Clin Nutr. 2000 ; 19: 417-423
22. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, et al. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 ; 12: 640-644 (Pubitemid 39280314)
23. Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007 ;: CD004597
24. Mazzotta P, Jeney CM. Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated fatty acids in the management of symptoms, survival, and quality of life. J Pain Symptom Manage. 2009 ; 37: 1069-1077
25. Persson C, Glimelius B, Ronnelid J, Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition. 2005 ; 21: 170-178 (Pubitemid 40255726)
26. Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006 ; 24: 3401-3407 (Pubitemid 46638896)
27. Mantovani G, Maccio A, Madeddu C, Gramignano G, Serpe R, Massa E, et al. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition. 2008 ; 24: 305-313
28. Mantovani G, Madeddu C, Maccio A, Gramignano G, Lusso MR, Massa E, et al. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev. 2004 ; 13: 1651-1659 (Pubitemid 39331888)
29. Mantovani G, Maccio A, Madeddu C, Gramignano G, Lusso MR, Serpe R, et al. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev. 2006 ; 15: 1030-1034 (Pubitemid 43823535)
30. Read JA, Beale PJ, Volker DH, Smith N, Childs A, Clarke SJ. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007 ; 15: 301-307 (Pubitemid 46295216)
31. Taylor LA, Pletschen L, Arends J, Unger C, Massing U. Marine phospholipids-a promising new dietary approach to tumor-associated weight loss. Support Care Cancer. 2010 ; 18: 159-170
32. Bauer JD, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy-a pilot study. Support Care Cancer. 2005 ; 13: 270-274 (Pubitemid 40576515)
33. Barber MD, Preston T, McMillan DC, Slater C, Ross JA, Fearon KC. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. Clin Sci (Lond). 2004 ; 106: 359-364 (Pubitemid 38553582)
34. Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond). 1997 ; 92: 215-221 (Pubitemid 27075725)
35. de Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC, Martin T. A randomized clinical trial with two omega 3 fatty acid enhanced oral supplements in head and neck cancer ambulatory patients. Eur Rev Med Pharmacol Sci. 2008 ; 12: 177-181
36. Bauer J, Capra S, Battistutta D, Davidson W, Ash S. Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr. 2005 ; 24: 998-1004
37. Farreras N, Artigas V, Cardona D, Rius X, Trias M, Gonzalez JA. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005 ; 24: 55-65
38. Braga M, Vignali A, Gianotti L, Cestari A, Profili M, Carlo VD. Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg. 1996 ; 162: 105-112
39. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002 ; 137: 174-180 (Pubitemid 34142134)
40. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009 ; 249: 355-363
41. Horie H, Okada M, Kojima M, Nagai H. Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition. Surg Today. 2006 ; 36: 1063-1068 (Pubitemid 44819449)
42. Klek S, Kulig J, Szczepanik AM, Jedrys J, Kolodziejczyk P. The clinical value of parenteral immunonutrition in surgical patients. Acta Chir Belg. 2005 ; 105: 175-179 (Pubitemid 40694516)
43. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995 ; 221: 327-338
44. Casas-Rodera P, Gomez-Candela C, Benitez S, Mateo R, Armero M, Castillo R, et al. Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: a prospective, randomized clinical trial. Nutr Hosp. 2008 ; 23: 105-110 (Pubitemid 351879617)
45. Argiles JM, Anker SD, Evans WJ, Morley JE, Fearon KC, Strasser F, et al. Consensus on cachexia definitions. J Am Med Dir Assoc. 11: 229-230
46. Kyle UG. ESPEN Guidelines: Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004 ; 24: 1430-1453 (Pubitemid 39517638)